[Skip to Content]
[Skip to Content Landing]
Article
August 1995

Familial Nonmedullary Thyroid CancerAn Emerging Entity That Warrants Aggressive Treatment

Author Affiliations

From the Department of Surgery, Mount Zion Medical Center of the University of California at San Francisco (Drs Grossman, Duh, Siperstein, and Clark and Ms Novosolov), and Department of Surgery, Cathay General Hospital, Taipei, Taiwan, Republic of China (Dr Tu).

Arch Surg. 1995;130(8):892-899. doi:10.1001/archsurg.1995.01430080094015
Abstract

Objective:  To determine whether familial nonmedullary thyroid carcinoma behaves like sporadic carcinoma of follicular cell origin.

Design:  Retrospective review.

Setting:  University medical center.

Patients:  Fourteen patients were treated for familial nonmedullary thyroid carcinoma between 1980 and 1994. Thirteen families were identified, with 30 affected individuals.

Interventions:  Patients were treated with total or completion total thyroidectomy. Thirteen additional operations were performed to control recurrent disease.

Main Outcome Measures:  Stage, recurrence, and survival. Patients were followed up for a mean of 6.5 years.

Results:  In our 14 patients, 13 tumors were multifocal, and six of these were bilateral. The incidences of lymph node metastasis and local invasion were both 57% (n=8). Seven patients (50%) had recurrences during follow-up.

Conclusions:  Familial nonmedullary thyroid carcinoma has a high incidence of multifocality and invasion and a high rate of local recurrence. Aggressive initial treatment and careful follow-up seem to be indicated.(Arch Surg. 1995;130:892-899)

×